Nyx Therapeutics Ltd is a New Zealand clinician-led therapeutics company building modern wellness products and care pathways for the local market. Founded by clinician-scientists, Nyx combines clinical insight, formulation science, regulatory discipline, and digital health thinking to improve how Kiwis access quality sleep-support and wellness medicines.
Crafting innovative formulations and delivering care through novel digital health platforms.
Nyx Therapeutics was founded by two practising New Zealand clinicians bringing complementary expertise across medicine, pharmacology, research and product strategy.
Co-founder · General Surgeon
Dr Dhruvesh Ramson is a clinician-scientist, pharmacologist, surgeon and entrepreneur. He brings experience across clinical medicine, pharmacology, academic research and product strategy. At Nyx, he contributes to clinical governance, formulation direction, Medsafe dossier planning and the development of clinician-led digital care pathways.
Co-founder · Anaesthetist
Dr Luke Perry is a pharmacologist, anaesthetist and clinical researcher. He brings expertise in perioperative medicine, clinical operations, research translation, protocol development and quality execution. At Nyx, he contributes to clinical strategy, product development, operational thinking and evidence-informed care models.
Interested in partnering with Nyx or learning more about our pipeline?